Hosted on MSN13h
AbbVie and Neomorph link on oncology/immunology glue degraders
AbbVie and Neomorph are forming a partnership and option-to-license agreement to develop molecular glue degraders, aiming to introduce a new class of treatments across oncology and immunology.
Blockmate investee Hivello enters strategic partnership with AIxBlock for AI apps to access decentralised computing power
Ha Dao, CEO & Co-Founder AIxBlock, echoed the sentiment: “Hivello’s expertise in node management complements our vision of decentralizing AI compute power. Together, we can create an ecosystem that ...